Global Quinidine Sulfate Market 2022-2026

Description

List of Tables

Technavio has been monitoring the quinidine sulfate market and it is poised to grow by $ 427.29 mn during 2022-2026, accelerating at a CAGR of 6.7% during the forecast period. Our report on the quinidine sulfate market provides a holistic analysis, market size and forecast, trends, growth drivers, challenges, and vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing incidence of malaria, robust pipeline and drug approvals, and increasing mergers and acquisitions.

The quinidine sulfate market analysis includes type segment and geographic landscape.

Technavio's quinidine sulfate market is segmented as below:

By Type

Malaria
Arrhythmias

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the strong funding for the eradication of malaria as one of the prime reasons driving the quinidine sulfate market growth during the next few years. Also, an increase in the incidence of arrhythmia and increasing awareness among people about quinidine sulfate supplements will lead to sizable demand in the market.

Quinidine sulfate market sizing
Quinidine sulfate market forecast
Quinidine sulfate market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading quinidine sulfate market vendors that include Bennet Pharmaceuticals Ltd., Buchler GmbH, Cipla Ltd., Ipca Laboratories Ltd., Lark Laboratories India Ltd., Merck and Co. Inc., Merck KGaA, PRISM INDUSTRIES LTD., Teva Pharmaceutical Industries Ltd., VIVAN Life Sciences Pvt. Ltd., Biophore India Pharmaceuticals Pvt. Ltd., Inga Laboratories P. Ltd., Koninklijke DSM NV, PMC Group Inc., PT Bio Farma, PT Sinkona Indonesia lestar, and Vital Laboratories Pvt. Ltd. Also, the quinidine sulfate market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Product Code: IRTNTR73837

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Disease Type

5.1 Market segments
Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
5.2 Comparison by Disease Type
Exhibit 26: Chart on Comparison by Disease Type
Exhibit 27: Data Table on Comparison by Disease Type
5.3 Malaria - Market size and forecast 2021-2026
Exhibit 28: Chart on Malaria - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Malaria - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Malaria - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Malaria - Year-over-year growth 2021-2026 (%)
5.4 Arrhythmias - Market size and forecast 2021-2026
Exhibit 32: Chart on Arrhythmias - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Arrhythmias - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Arrhythmias - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Arrhythmias - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Disease Type
Exhibit 36: Market opportunity by Disease Type ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Bennet Pharmaceuticals Ltd.
Exhibit 85: Bennet Pharmaceuticals Ltd. - Overview
Exhibit 86: Bennet Pharmaceuticals Ltd. - Product / Service
Exhibit 87: Bennet Pharmaceuticals Ltd. - Key offerings
10.4 Buchler GmbH
Exhibit 88: Buchler GmbH - Overview
Exhibit 89: Buchler GmbH - Product / Service
Exhibit 90: Buchler GmbH - Key offerings
10.5 Cipla Ltd.
Exhibit 91: Cipla Ltd. - Overview
Exhibit 92: Cipla Ltd. - Business segments
Exhibit 93: Cipla Ltd. - Key news
Exhibit 94: Cipla Ltd. - Key offerings
Exhibit 95: Cipla Ltd. - Segment focus
10.6 Ipca Laboratories Ltd.
Exhibit 96: Ipca Laboratories Ltd. - Overview
Exhibit 97: Ipca Laboratories Ltd. - Product / Service
Exhibit 98: Ipca Laboratories Ltd. - Key offerings
10.7 Lark Laboratories India Ltd.
Exhibit 99: Lark Laboratories India Ltd. - Overview
Exhibit 100: Lark Laboratories India Ltd. - Product / Service
Exhibit 101: Lark Laboratories India Ltd. - Key offerings
10.8 Merck and Co. Inc.
Exhibit 102: Merck and Co. Inc. - Overview
Exhibit 103: Merck and Co. Inc. - Business segments
Exhibit 104: Merck and Co. Inc. - Key news
Exhibit 105: Merck and Co. Inc. - Key offerings
Exhibit 106: Merck and Co. Inc. - Segment focus
10.9 Merck KGaA
Exhibit 107: Merck KGaA - Overview
Exhibit 108: Merck KGaA - Business segments
Exhibit 109: Merck KGaA - Key news
Exhibit 110: Merck KGaA - Key offerings
Exhibit 111: Merck KGaA - Segment focus
10.10 PRISM INDUSTRIES LTD.
Exhibit 112: PRISM INDUSTRIES LTD. - Overview
Exhibit 113: PRISM INDUSTRIES LTD. - Product / Service
Exhibit 114: PRISM INDUSTRIES LTD. - Key offerings
10.11 Teva Pharmaceutical Industries Ltd.
Exhibit 115: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 116: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 117: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 118: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 119: Teva Pharmaceutical Industries Ltd. - Segment focus
10.12 VIVAN Life Sciences Pvt. Ltd.
Exhibit 120: VIVAN Life Sciences Pvt. Ltd. - Overview
Exhibit 121: VIVAN Life Sciences Pvt. Ltd. - Product / Service
Exhibit 122: VIVAN Life Sciences Pvt. Ltd. - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 123: Inclusions checklist
Exhibit 124: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 125: Currency conversion rates for US$
11.4 Research methodology
Exhibit 126: Research methodology
Exhibit 127: Validation techniques employed for market sizing
Exhibit 128: Information sources
11.5 List of abbreviations
Exhibit 129: List of abbreviations